# Stereotactic Focal Radiotherapy as an Alternative Treatment to Active Surveillance for Low and Intermediate Risk Prostate Cancer

> **NCT07152067** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Centre Hospitalier Universitaire de Liege** · enrollment: 146 (estimated)

## Conditions studied

- Macroscopic Tumor Visualized at MRI
- Tumor Size Allowing Partial Prostate Treatment Volume
- CAPRA SCORE ≤5

## Interventions

- **RADIATION:** Stereotactic Body Radiation Therapy (SBRT)

## Key facts

- **NCT ID:** NCT07152067
- **Lead sponsor:** Centre Hospitalier Universitaire de Liege
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09
- **Primary completion:** 2030-09-01
- **Final completion:** 2033-09-01
- **Target enrollment:** 146 (ESTIMATED)
- **Last updated:** 2025-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07152067

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07152067, "Stereotactic Focal Radiotherapy as an Alternative Treatment to Active Surveillance for Low and Intermediate Risk Prostate Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT07152067. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*